Mother’s campaign wins experimental drug for son at Memphis-based St. Jude
Dr. Ari VanderWalde, the new associate vice chancellor of clinical trial research at the University of Tennessee Health Science Center said cases like Josh’s are extremely complicated, highly charged and center not only on the patient seeking an unproven drug, but the risk of jeopardizing others in the future who would get it.

